The present invention relates to the field of optical nano-imaging bioassays and discloses a
bioassay and
optical imaging method based on a one-dimensional nanophotonic platform. The method comprises the following steps: (1) a beam of
white light is irradiated along a non-periodic direction on a one-dimensional
nanostructure, and the generated scattering and
diffraction signals are received using a
microscope or
mobile phone; (2) defects in the one-dimensional
nanostructure disrupt the distribution of the
local field, reduce the scattering intensity of the
nanostructure, and change the color of the one-dimensional nanostructure; (3) in the visible light region, in addition to a scattering peak, another new
diffraction peak can improve the sensitivity of the
spectral response, allowing the measurement of size differences of 20 nanometers; (4) by modifying antibodies on the surface of the one-dimensional nanostructure, the detection of a single
virus can be achieved, which is beneficial for the early diagnosis of
in vitro diseases, especially in underdeveloped areas and areas with harsh biological experimental conditions. The technology is simple to operate, low-cost, and conducive to the rapid and high-
throughput detection of nanoscale samples.